Founded in 2018, Vinehealth, a digital health startup based in London, offers digital support for cancer patients and SaaS for R&D. It built an app that provides customized support for cancer patients. In addition to this, Vinehealth makes it easier to collect patient-reported outcome data that includes drug development and clinical trials. It has closed a $5.5 million seed round as it prepares to expand into the U.S.
Co-founder and CTO Georgina Kirby described this as a “late seed”. At the same time, there’s a planned Series A in the next 12-18 months, which is led by Talis Capital and participation from previous investors Playfair Capital and Ascension.
Several angel investors including Keith Gibbs, former CEO of AXA PPP Healthcare; Pam Garside, partner at Newhealth; Voyagers Health-Tech Fund, led by David Rowan, founding editor of Wired; David Giampaolo, healthcare entrepreneur and founder of P.I., also joined the funding round.
This startup uses behavioral science and A.I. to deliver timely patient support and nudges. It helps the patients to manage their treatment by themselves